Core Viewpoint - The report from Credit Lyonnais indicates that Lenovo Group is expected to achieve a profit of $480 million for the first fiscal quarter ending in June, which is 47% higher than the market expectation of $326 million [1] Financial Performance - The non-GAAP net profit, excluding the impact of convertible bonds and warrants, is projected to be $400 million, an 11% increase from previous forecasts [1] - The GAAP earnings estimates for fiscal year 2026 have been raised by 13% to $1.687 billion, while non-GAAP earnings estimates have been increased by 4% to $1.729 billion [1] - The GAAP earnings estimates for fiscal years 2027 and 2028 have also been adjusted upward by 9% [1] Business Segment Performance - The Intelligent Devices Group (IDG) revenue is expected to increase by 14% quarter-over-quarter, driven by demand in the U.S. market [1] Target Price and Rating - The target price for Lenovo has been raised from HKD 11 to HKD 12, with a reaffirmation of the "outperform" rating [1]

Company Performance - Masimo reported quarterly earnings of $1.33 per share, exceeding the Zacks Consensus Estimate of $1.23 per share, and up from $0.86 per share a year ago, representing an earnings surprise of +8.13% [1] - The company posted revenues of $370.9 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.59%, but down from $496.3 million year-over-year [2] - Over the last four quarters, Masimo has consistently surpassed consensus EPS estimates and revenue estimates [2] Future Outlook - The immediate price movement of Masimo's stock will depend on management's commentary during the earnings call and the sustainability of earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $1.14 on revenues of $369.36 million, and for the current fiscal year, it is $4.98 on revenues of $1.52 billion [7] - The estimate revisions trend for Masimo was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Medical - Instruments industry, to which Masimo belongs, is currently ranked in the bottom 37% of over 250 Zacks industries, suggesting potential challenges for stock performance compared to higher-ranked industries [8] - The performance of Masimo's stock may also be influenced by the overall outlook for the industry [8]

Core Viewpoint - ONE Gas reported quarterly earnings of $0.53 per share, matching the Zacks Consensus Estimate, and showing an increase from $0.48 per share a year ago [1] - The company posted revenues of $423.74 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 4.86% and up from $354.14 million year-over-year [2] Earnings Performance - The earnings surprise for the previous quarter was +7.03%, with actual earnings of $1.98 per share compared to an expected $1.85 [1] - Over the last four quarters, ONE Gas has surpassed consensus EPS estimates two times [1] Revenue Performance - The company has also topped consensus revenue estimates two times over the last four quarters [2] Stock Performance - ONE Gas shares have increased by approximately 5.9% since the beginning of the year, while the S&P 500 has gained 7.6% [3] Future Outlook - The company's earnings outlook is crucial for investors, including current consensus earnings expectations for upcoming quarters [4] - The current consensus EPS estimate for the next quarter is $0.54 on revenues of $383.09 million, and for the current fiscal year, it is $4.29 on revenues of $2.43 billion [7] Industry Context - The Utility - Gas Distribution industry is currently in the top 30% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5][6]

Jushi Holdings Inc. (JUSHF) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.01 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post a loss of $0.06 per share when it actually produced a loss of $0.09, delivering a surprise of -50%. Over the last four quarters, the company has not been able to surpass consensus EPS estimates. Jushi Holdings Inc. shares ha ...

Core Insights - Stem (STEM) is scheduled to report its second-quarter 2025 earnings on August 7, with revenue estimates at $33.1 million, indicating a 2.65% decrease from the previous year [1] - The consensus estimate for loss is $3 per share, unchanged over the past 90 days, but represents a 31.82% improvement from the same quarter last year [1] - Stem has beaten earnings estimates in three of the last four quarters, with an average surprise of 12.34% [1] Performance Drivers - The performance in Q2 2025 is expected to be driven by the growth of the solar asset performance management software platform, Powertrack, which saw a 10% sequential and 24% year-over-year increase in solar ARR [3] - A 27% workforce reduction announced on April 9 is anticipated to generate $30 million in annual cash savings, with $24 million expected in 2025, aligning with the company's software-first strategy [4] - Profitability is projected to improve throughout the year due to better management of operating expenses and a shift in product mix towards high-margin software and edge devices [5] Seasonal Trends - Seasonal trends may have slightly impacted bookings in Q2, with lower total bookings in Q1 due to seasonality, typically seeing higher volumes in the second half of the year [6] - Despite an increase in key metrics like Contracted Backlog and CARR in Q1, the seasonal pattern may have constrained overall revenue growth in early Q2 [6] Earnings Outlook - According to the Zacks model, the combination of a positive Earnings ESP and a Zacks Rank of 1, 2, or 3 increases the likelihood of an earnings beat, but Stem currently has an Earnings ESP of 0.00% and a Zacks Rank 3 [7]

Company Performance - Recursion Pharmaceuticals reported a quarterly loss of $0.41 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.35, representing an earnings surprise of -17.14% [1] - The company posted revenues of $19.22 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 33.71%, compared to revenues of $14.42 million a year ago [2] - Over the last four quarters, Recursion Pharmaceuticals has not surpassed consensus EPS estimates and has topped consensus revenue estimates only once [2] Stock Movement and Outlook - Shares of Recursion Pharmaceuticals have declined approximately 14.2% since the beginning of the year, contrasting with the S&P 500's gain of 7.6% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is -$0.32 on revenues of $13.37 million, and for the current fiscal year, it is -$1.35 on revenues of $68.39 million [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Recursion Pharmaceuticals belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor decisions [5]

Company Performance - Prothena reported a quarterly loss of $1.86 per share, which was worse than the Zacks Consensus Estimate of a loss of $1.11, and a significant decline from earnings of $1.22 per share a year ago, indicating an earnings surprise of -67.57% [1] - The company posted revenues of $4.42 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 79.2%, and a stark decrease from year-ago revenues of $132.01 million [2] - Over the last four quarters, Prothena has only surpassed consensus EPS estimates once and has not beaten consensus revenue estimates during the same period [2] Stock Performance - Prothena shares have declined approximately 50.8% since the beginning of the year, contrasting with the S&P 500's gain of 6.1% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.96 on revenues of $24.8 million, and for the current fiscal year, it is -$3.94 on revenues of $39.34 million [7] Industry Outlook - The Medical - Biomedical and Genetics industry, to which Prothena belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, suggesting that the industry outlook could negatively impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could be a useful metric for investors [5]

Core Viewpoint - Oddity Tech reported quarterly earnings of $0.92 per share, exceeding the Zacks Consensus Estimate of $0.88 per share, and showing an increase from $0.82 per share a year ago, indicating a positive earnings surprise of +4.55% [1] Financial Performance - The company achieved revenues of $241.14 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.83% and reflecting a year-over-year increase from $192.77 million [2] - Over the last four quarters, Oddity Tech has consistently surpassed consensus EPS and revenue estimates [2] Stock Performance - Oddity Tech shares have increased approximately 70.6% since the beginning of the year, significantly outperforming the S&P 500's gain of 6.1% [3] Future Outlook - The company's earnings outlook will be crucial for assessing future stock performance, with current consensus EPS estimates at $0.32 for the coming quarter and $2.04 for the current fiscal year [7] - The Zacks Rank for Oddity Tech is currently 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6] Industry Context - The Internet - Software industry, to which Oddity Tech belongs, is currently ranked in the top 32% of over 250 Zacks industries, suggesting a favorable environment for stock performance [8]

Core Insights - W.W. Grainger, Inc. reported weaker-than-expected earnings for Q2, with earnings per share (EPS) of $9.97, missing the analyst consensus estimate of $10.04, while quarterly sales of $4.554 billion exceeded the estimate of $4.522 billion [1] - The company revised its FY2025 GAAP EPS guidance down from a range of $39.00-$41.50 to $38.50-$40.25, but raised its sales guidance from $17.600 billion-$18.100 billion to $17.900 billion-$18.200 billion [2] - CEO D.G. Macpherson emphasized the company's focus on customer relationships and innovation, noting that performance was affected by tariff-related factors, but expressed confidence in the company's ability to create value amid macroeconomic uncertainty [3] Analyst Reactions - Following the earnings announcement, RBC Capital analyst Deane Dray maintained a Sector Perform rating on W.W. Grainger and lowered the price target from $1,176 to $1,007 [6] - Loop Capital analyst Chris Dankert also maintained a Hold rating and reduced the price target from $1,000 to $950 [6]

Market Performance - Global markets experienced a general decline, with MSCI Global down by 2.2%, MSCI Developed down by 2.3%, and MSCI Emerging down by 1.6% [8][15][17] - Among developed markets, the Australian S&P 200 showed the best performance with a decline of only 0.1%, while the French CAC40 was the weakest, down by 3.7% [8][15] - In the emerging markets, the Taiwan Weighted Index was the best performer, up by 0.3%, while the Hang Seng Index was the worst, down by 3.5% [8][15] Trading Sentiment - Trading volume increased across major indices, with the Hang Seng Index reaching 198 billion shares and a turnover of 736.1 billion USD, while the S&P 500 had a turnover of 58.6 billion USD [24] - Investor sentiment in the Hong Kong market improved, with short-selling accounting for 13.5% of total turnover, while North American sentiment showed a decline [24][29] - Volatility increased in the US markets, while it decreased in the Hong Kong market [24][30] Fund Flows - Global macro liquidity expectations turned more accommodative, with the market anticipating 2.4 rate cuts by the Federal Reserve within the year [53][56] - Significant capital inflows were observed in the Hong Kong market, with a total of 18.3 billion HKD flowing in during the last week [61][65] - The net inflow of funds into the Hong Kong market was primarily driven by stable foreign capital, amounting to 13.8 billion HKD [61] Earnings Expectations - The earnings expectations for the Hang Seng Index were revised down from 2195 to 2191 for 2025, with the financial sector seeing the largest upward revision [66][68] - The S&P 500's earnings expectations were adjusted upward from 265 to 267, with the technology sector experiencing the most significant increase [66][68] - The Eurozone STOXX50 index saw a slight downward revision in earnings expectations from 336 to 335 for 2025 [66][68]